First LR, Smith BR, Lipton J., et al. Isolated thrombocytopenia after allogenic bone marrow transplantation: existence of transient and chronic thrombocytopenic syndromes. Blood. 1985;65:368-374.
2.
Peralvo J.Bacigalupo A., Pittaluga PA, et al. Poor graft function associated with graft-versus-host disease after allogenic marrow transplantation. Bone Marrow Transplant . 1987;2:279-285.
3.
Anasetti C., Rybka W., Sullivan KM, et al. Graft-v-host disease is associated with autoimmune-like thrombocytopenia . Blood. 1989;73:1054-1058.
4.
Bierling P., Cordonnier C., Fromont P., et al. Acquired autoimmune thrombocytopenia after allogenic bone marrow transplantation. Br J Haematol. 1985;59:643-646.
5.
Chong BH, Ho SJAutoimmune thrombocytopenia. J Thromb Haemost. 2005;3:1763-1772.
6.
Kuwana M., Kaburaki J., Ikeda Y.Autoreactive T cells to platelet GPIIb/IIIa in immune thrombocytopenic purpura . J Clin Invest. 1998;102:1393-1402.
7.
Kuwana M., Kaburaki J., Kitasato H., et al. Immunodominant epitopes on glycoprotein IIb/IIIa recognized by autoreactive T cells in patients with immune thrombocytopenic purpura. Blood. 2001;98:130-139.
8.
Ting SS, Ziegler JB, Vowels MRAcquired autoimmune thrombocytopenia post-bone marrow transplantation for severe combined immunodeficiency. Bone Marrow Transplant. 1998;21:841-843.
9.
McMillan R., Tani P., Millard F., et al. Platelet-associated and anti-glycoproteins in chronic ITP. Blood. 1987;70: 1040-1045.
10.
Stern LJ, Brown JH, Jardetzky TS, et al. Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature. 1994; 368:215-221.
11.
Kuwana M., Kaburaki J., Pandey JP, et al. HLA class II alleles in Japanese patients with immune thrombocytopenic purpura. Associations with anti-platelet glycoprotein autoantibodies and responses to splenectomy. Tissue Antigens. 2000;56:337-343.
12.
Yamanouchi J., Hato T., Tamura T., et al. Identification of an epitope on glycoprotein IIb-IIIa that is recognized by HLA-DRB1*0405-restricted CD4+ `superior' T cells from a patient with immune thrombocytopenic purpura. J Thromb Haemost. 2004;2:348-350.
13.
Nomura S., Matsuzaki T., Ozaki Y., et al. Clinical significance of HLA-DRB1*0410 in Japanese patients with idiopathic thrombocytopenic purpura. Blood. 1998;91: 3616-3622.